Under construction – not a live service
Sign in
Taking people in CanadaNo phase

OBEDIAM: Therapeutic Patient Education in Adults Living With Obesity, Diabetes, and Metabolic Disorders

Key facts

Where
Québec, CanadaSee the site

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 80 years old?

Source: NCT07668661, who can take part

Where in Canada

  • CHU de Quebec-Universite LavalQuébec, CanadaTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
CHU de Quebec-Universite Laval
Trial code
NCT07668661
Record updated
3 November 2026
Original description
The goal of this observational study is to learn about the acceptability and feasibility of a therapeutic patient education program in adults living with an obesity. The main question it aims to answer is:Read full original descriptionShow less

OBEDIAM: a Pilot Study of Therapeutic Patient Education in Adults Living With Obesity, Diabetes, and Metabolic Disorders

The goal of this observational study is to learn about the acceptability and feasibility of a therapeutic patient education program in adults living with an obesity. The main question it aims to answer is:

Is the intervention of therapeutic patient education acceptable for patients living with an obesity?

Participants will answer questionnaires and participate to focus groups before and up to nine months after the intervention.

Inclusion: Aged 18 to 80; living with obesity defined by a BMI ≥ 30 kg/m2 with a stage ≥ 2 according to the Edmonton Obesity Staging System (EOSS); and at least one obesity-related comorbidity, including type 2 diabetes, steatohepatitis associated with metabolic dysfunction (MASH), polycystic ovary syndrome or osteoarthritis; speaking and understanding French; having access to the Internet.

Exclusion: inability to provide informed consent or to respond to questionnaires.

ClinicalTrials.gov NCT07668661